Ksilink’s Executive Team
Antoine de Lacombe
Graduated from Université Paris-Dauphine in management and Institut d’Etudes Politiques de Paris in corporate finance, Antoine started with Ernst & Young. He then joined a privately-owned group where he gained experience in corporate finance and restructuring. Antoine is the managing director of Ksilink.
Mona Boyé, PhD
Head of Business Strategy
With a PhD in molecular Biology from Cardiff University, UK, Mona worked several years as a Technology Transfer Officer at the CNRS and was heading a team of Innovation and Matchmaking Officers at the trinational, industrial cluster BioValley. She accumulated over 15 years of experience in technology transfer and open innovation before joining the Ksilink team in 2016.
François Kien, PhD
R&D Operations Manager
With a PhD in Virology from the University of Strasbourg, François spent 9 years in the International Network of Institut Pasteur as scientist, HSE and PR officer. At Ksilink he started as Administrative Coordinator in 2014 and became R&D Operations Manager in 2017.
Peter Sommer, PhD
Head of Science
Graduated in Virology from the University of the Saarland, Peter worked on retroviruses at the Institut Pasteur in Paris and headed a translational research team at the Institut Pasteur Korea in Seoul. Peter has gathered 15 years of experience in translational research and drug discovery in Europe and Asia before joining Ksilink in 2014.
Laurent Brino, PhD
Head of Early Drug Discovery
With a PhD in molecular biology and biochemistry from the University of Strasbourg, Laurent spent 4 years in the belgian biotech Eurogentec before managing as Scientific facility coordinator the RNAi and drug screening facility at IGBMC in Strasbourg since 2005. He was also Project Manager for the Cancéropôle Grand Est from 2005 to 2010. He joined Ksilink in December 2019.
Arnaud Ogier, PhD
Head of Images and Data Mining
With a PhD in Applied Mathematics from the University of Rennes (IRISA/INRIA), Arnaud spent 9 years as scientist in Institut Pasteur Korea. In 2014 he joined Ksilink developing Artificial Intelligence / Deep Learning dedicated to drug discovery.